The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.

This educational hub has been supported by Boehringer Ingelheim. Boehringer Ingelheim has had no influence over the content. This educational hub is not intended for UK or IRELAND based physicians.

Close X
Other videos you might like

Recent Videos


ESC 23 Late-Breaker Discussion: The STEP HFpEF Trial

Harriette Van Spall, Mikhail Kosiborod,

Watch time: 13m 24s


ESC 23: Day 1 Wrap-Up with Dr Alasnag and Dr Al-Shaibi

Mirvat Alasnag, Khaled Al-Shaibi,

Watch time: 13m 28s


Obesity Management Strategies in 2023

Harold Bays,

Watch time: 17m 7s


EASD 22: SURMOUNT-MMO: Tirzepatide in Obese Type II Diabetes Patients

Steven E Nissen,

Watch time: 7m 48s